Gamma Knife Switzerland
Reviewed by the SwissAtlas coordination team · Last updated:
Evidence preparation before neurological review guides the way families prepare high-stakes decisions under cross-border pressure.
Reviewed by the SwissAtlas coordination team · Last updated:
Evidence preparation before neurological review guides the way families prepare high-stakes decisions under cross-border pressure.
Gamma Knife treatment planning depends entirely on imaging quality. A recent contrast-enhanced MRI — ideally within four weeks of the planned treatment date for active lesions — is the primary planning input. For AVM cases, angiography (DSA) is required in addition to MRI to define nidus geometry and feeding vessel anatomy. For trigeminal neuralgia, dedicated high-resolution MRI sequences covering the trigeminal root entry zone are required rather than standard brain MRI.
Neurological treatment coordination in Switzerland is aligned with standards maintained by the Swiss Neurological Society.
Imaging submitted for remote file review must be in native DICOM format with full sequence metadata. JPEG exports and paper printouts cannot be used for Gamma Knife planning because windowing access and spatial calibration data are lost. Families should request encrypted DICOM media from the imaging centre at the same time as the clinical report — not after, when the practical logistics of retrieving archived data from a prior study add delay.
SwissAtlas supports international families navigating complex medical situations with discretion and clarity. Each case is handled with strict confidentiality and a structured coordination approach. Designed for sensitive situations requiring discretion and clarity.
The Leksell Gamma Knife delivers 192–201 cobalt-60 beams converging at submillimetre precision on the defined target volume. No surgical incision is required. The primary indications treated at Swiss Gamma Knife centres include: brain metastases (single and oligometastatic), vestibular schwannoma (acoustic neuroma), meningioma, arteriovenous malformations, trigeminal neuralgia, pituitary adenoma, and selected recurrent or residual primary brain tumours where surgical re-intervention carries unacceptable risk.
Gamma Knife is not indicated for large lesions (most programmes apply upper size limits around 3–3.5 cm in greatest dimension for most tumour types), for lesions requiring rapid volume reduction due to mass effect, or for diffuse or multifocal disease patterns where the dose distribution advantage is lost. Candidacy is confirmed through pre-treatment consultation that reviews imaging, prior treatment history, and current clinical status.
Treatment is conducted in a single outpatient session. Stereotactic frame placement — a rigid head frame fixed under local anaesthesia in most adult cases, or thermoplastic mask-based immobilisation in frameless systems — precedes the planning MRI and dose calculation. Treatment delivery runs one to four hours depending on lesion number and complexity. Families should plan for a full-day schedule, with discharge typically in the afternoon. No general anaesthesia is required for frame-based cases in most adults.
Post-treatment follow-up is structured by indication. Brain metastases typically require MRI at two to three months and then every three months for the first year. Vestibular schwannoma and meningioma follow-up is less frequent: MRI at six and twelve months, then annually. Trigeminal neuralgia response is assessed clinically at one and three months. Families coordinating follow-up from their home country should confirm that their local imaging centre can produce the specific sequences required for Swiss post-treatment comparison before discharge.
Gamma Knife radiosurgery at Swiss centres typically costs CHF 15,000–28,000 for a single treatment session, covering the planning consultation, stereotactic frame or mask preparation, dose planning, treatment delivery, and post-treatment observation. For multiple lesions treated in a single session, cost may be higher depending on planning complexity. Total in-country stay for a standard case is two to three days — one for planning imaging and one for treatment — making this one of the most logistically efficient advanced neurological interventions available in Switzerland.
Complete documentation for Gamma Knife candidacy review includes: recent contrast-enhanced MRI in DICOM format (within four weeks for active or growing lesions), prior radiation history with dose-volume histograms if applicable, full pathology or cytology report for tumour cases, current medication list including anticoagulants, and a chronological treatment summary. For AVM cases, digital subtraction angiography in addition to MRI is required before planning can be initiated. Assembling this documentation before first contact allows candidacy assessment to proceed without additional correspondence delays.
SwissAtlas operates exclusively as a non-medical coordination platform. We do not provide clinical services, diagnoses, or treatment recommendations. All medical decisions are made by licensed Swiss institutions.
The pre-treatment evaluation for Gamma Knife radiosurgery is as important as the procedure itself. The Swiss centre will review all available imaging before confirming candidacy — this review is not a formality but a genuine assessment of whether the lesion characteristics, location, and size place the patient within the evidence-based treatment parameters for this modality. Families should not assume that a treating oncologist's or neurologist's suggestion of Gamma Knife translates automatically to Swiss institutional acceptance; candidacy is confirmed after imaging review, not before.
Required documentation for a Gamma Knife pre-evaluation: MRI with gadolinium contrast, all available sequences (T1 post-contrast, T2, FLAIR, DWI), acquired within the past four to six weeks where possible; prior treatment history including previous surgery reports and radiotherapy records if applicable; pathology report if histological diagnosis has been established. For AVM cases, digital subtraction angiography (DSA) is typically required in addition to MRI. All imaging should be submitted in DICOM format on CD or via secure file transfer — printed films are not usable for stereotactic planning.
The treatment day itself is managed as a day procedure. The patient arrives in the morning, the stereotactic frame is applied under local anaesthesia, a planning MRI or CT is acquired with the frame in place, the dosimetry plan is calculated by the physics team, the treatment is delivered (30–60 minutes typically), the frame is removed, and the patient is observed for two to four hours before discharge. Most patients can travel home the following day. The primary post-treatment restriction is avoiding activities that risk head trauma for two to four weeks.
SwissAtlas coordinates non-clinical sequencing, documentation flow, and logistics governance while licensed institutions retain medical decision authority.
Records should be assembled as chronology with unresolved questions so specialist review can proceed without avoidable interpretation gaps.
Budgets should be scenario-based because pathway scope can evolve after deeper institutional evidence review.
Confidentiality is strengthened by role-based recipient controls and approved channels defined before high-sensitivity updates begin.
Timelines are safer when logistics commitments are tied to confirmed milestones rather than assumptions made before candidacy is established.
Confidential access to private medical care in Switzerland.
SwissAtlas operates at the intersection of discretion, structure, and access. Unlike traditional intermediaries, we do not promote specific clinics or treatments. Our role is to provide a neutral, structured, and confidential coordination layer for international patients navigating complex medical situations. This approach allows families to move forward with clarity, without pressure, and without exposure.
SwissAtlas is designed for: international families seeking discretion; patients requiring fast and structured access; situations where clarity and confidentiality are essential.
No medical advice. No pressure. Only structured coordination.
For the complete strategic framework, review medical travel in Switzerland, treatment in Switzerland for international patients, and private healthcare Switzerland.